Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Locally Advanced Breast Cancer × Hydralazine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Refractory Solid Tumors 1 Locally Advanced Breast Cancer 1

Interventions

pertuzumab 2 Paclitaxel 2 Carboplatin 2 pegfilgrastim 1 Trastuzumab 1 Hydralazine 1 Doxorubicin 1 Docetaxel 1 Cyclophosphamide 1 Clinical Protocols 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00395655 2006-11-03

Hydralazine and Valproate Added to Chemotherapy for Breast Cancer

National Institute of Cancerología

Phase 2 Terminated

Locally Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡